Doctors may not be aware of how much promotion they are exposed to. This is both the most difficult area to research and the most important. Therefore, as much as possible, research on the effect of promotion on behaviour should avoid relying on self-report data to show causal relationships. Self-report data are appropriate for finding out what people think is happening, or how they want to present themselves to others, but in this area, that may be far from the reality. This review looks at the evidence for several different possible effects of promotion on behaviour. These are the impact of promotion on individual prescribing behaviour, on overall drug sales, and on requests for formulary additions; the effect of DTCA on consumers’ decisions, the effect of promotion on the content of continuing medical education courses, and the impact of industry funding on research outcomes.
Cite this article:
Clement V. L. Lim. A Review on The Impact of Pharmaceutical Promotions on Prescribing Behaviour. Asian Journal of Management. 2021; 12(3):291-6. doi: 10.52711/2321-5763.2021.00044
Clement V. L. Lim. A Review on The Impact of Pharmaceutical Promotions on Prescribing Behaviour. Asian Journal of Management. 2021; 12(3):291-6. doi: 10.52711/2321-5763.2021.00044 Available on: https://ajmjournal.com/AbstractView.aspx?PID=2021-12-3-9
1. A. Tamil Selvan, C. Jothibaskara Mohan, S. Karpagam Kumara Sundari, R. Suthakaran. Study on Role of Postmarketing Surveillance in New Drug Development. Asian J. Management 4(1): Jan.-Mar. 2013 page 12-15.
2. Ashish Kumar Srivastava, Saket Ranjan Praveer, Charu Yadav, Decision Variables of Purchase Intention: A Multivariate Analysis of Promotional Tools. Asian J. Management 2(2): April-June, 2011 page 51-56.
3. Becker, Marshall H. Stolley, Paul D. Lasagna, Louis. McEvilla, Joseph D. Sloane, Lois M. Differential education concerning therapeutics and resultant physician prescribing patterns. Journal of Medical Education 1972;47: 118‐127.
4. Berings, D. Blondeel, L. Habraken, H. The effect of industry‐independent drug information on the prescribing of benzodiazepines in general practice. European Journal of Clinical Pharmacology 1994; 46: 501‐505.
5. Bower, Anthony D. Burkett, Gary L. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. Journal of Family Practice 1987; 24: 612‐616.
6. Caudill, T. Shawn. Johnson, Mitzi S. Rich, Eugene C. McKinney, W. Paul. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Archives of Family Medicine 1996; 5: 201‐206.
7. Cockerill, Rhonda. Williams, Paul. Report on the 1989 survey of the dispensing practices and attitudes toward prescription drugs of Ontario pharmacists. Toronto: Province of Ontario; 1990.
8. Cormack, M. A. Howells, E. Factors linked to the prescribing of benzodiazepines by general practice principals and trainees. Family Practice 1992; 9: 466‐471.
9. Curry, Lynn. Putnam, R. Wayne. Continuing medical education in Maritime Canada: the methods physicians use, would prefer and find most effective. Canadian Medical Association Journal 1981; 124: 563‐566.
10. Darekar A. B., Zope Janhavi S., Saudagar R. B. Current Scenario of Global and Indian Pharmaceutical Marketing and Management. Asian J. Res. Pharm. Sci. 2016; 6(2): 95-100.
11. Dasta, Joseph F. Visconti, James A. Hawksworth, K. The adoption of clarithromycin by university‐based physicians during its first year of commercial availability. Journal of Pharmaceutical Marketing & Management 1995; 9: 3‐20.
12. Dhara Parekh, Pankaj Kapupara, Ketan Shah. Digital Pharmaceutical Marketing: A Review. Research J. Pharm. and Tech. 9(1): Jan., 2016; Page 108-112.
13. Gönül, Füsun. F. Carter, Franklin. Petrova, Elina. Srinivasan, Kannan. Promotion of prescription drugs and its impact on physiciansʹ choice behavior. Journal of Marketing 2001; 65: 79‐90.
14. Haayer, Flora. Rational prescribing and sources of information. Social Science and Medicine 1982; 16:2017‐2023.
15. Hemminki, Elina. The effect of a doctor’s personal characteristics and working circumstances on the prescribing of psychotropic drugs. Medical Care 1974; 12: 351‐357.
16. Lad P, Muragundi P, Ligade VS. Digitalize Pharmaceutical Marketing: Medical Representative Perspective. Research J. Pharm. and Tech. 2017; 10(7): 2179-2182.
17. Lurie, Nicole. Rich, Eugene C. Simpson, Deborah E. Meyer, Jeff. Schiedermayer, David L. Goodman, Jesse L. McKinney, W. Paul. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. Journal of General Internal Medicine 1990; 5: 240‐243.
18. Madhusudan Narayan, Birajit Mohanty, Mahesh Kumar. Examining the Effect of Marketing Promotional strategies of Pharmaceutical Companies on Doctors’ Prescription Behaviour. Research J. Pharm. and Tech. 2020; 13(10): 4888-4894.
19. Mapes, Roy. Aspects of British general practitioners’ prescribing. Medical Care 1977; 15: 371‐381.
20. Matalia, Ned. Journal advertising works! Three studies say so! Medical Marketing & Media 1994; 29:12‐14, 16, 18‐20.
21. Md. Yaqub Khan, Poonam Gupta, Dipendu Goswami, Bipin Bihari, Vikas Kumar Verma. A Review on Marketing of OTC Drugs. Asian J. Res. Pharm. Sci. 2013; Vol. 3: Issue 2, Pg 72-78.
22. Orlowski, James P. Wateska, Leon. The effects of pharmaceutical firm enticements on physician prescribing patterns: there’s no such thing as a free lunch. Chest 1992; 102: 270‐ 273.
23. Peay, Marilyn Y. Peay, Edmund R. Patterns of preference for information sources in the adoption of new drugs by specialists. Social Science and Medicine 1990; 31:467‐476.
24. Pestun I. V., Mnushko Z. M., Ievtushenko O. M.. Marketing research of the Pharmaceutical market in Ukraine: Peculiarities, Trends, Problems, Tendencies. Research J. Pharm. and Tech. 2019; 12(4): 2049-2054.
25. Rejikumar. G, Aswathy Asokan. A, Gopi Kumar. V. Pharmaceutical Marketing: Directions for Customer Orientation. Research J. Pharm. and Tech 2018; 11(8): 3283-3289.
26. Somil Gupta, Shourya Gupta. New product launch through social media and point of sale promotion. Asian J. Management 5(2): April-June, 2014 page 183-187.
27. Stolley, Paul D. Becker, Marshall H. Lasagna, Louis. McEvilla, Joseph D. Sloane, Lois M. The relationship between physicians characteristics and prescribing appropriateness. Medical Care 1972; 10: 17‐28.
28. Strickland‐Hodge, B. Jepson, M. H. Identification and characterization of early and late prescribers in general practice. Journal of the Royal Society of Medicine 1982; 75:341‐345.
29. Stross, Jeoffrey K. Information sources and clinical decisions. Journal of General Internal Medicine 1987; 2:155‐159.
30. Taylor, Ross J. Bond, Christine M. Change in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice. British Journal of General Practice 1991; 41:244‐248.
31. Walton, Harold. Ad recognition and prescribing by physicians. Journal of Advertising Research 1980; 20: 39‐48.